Review



recombinant mouse protein s pros1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems recombinant mouse protein s pros1
    Recombinant Mouse Protein S Pros1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+s+ps/Recombinant+Mouse+Protein+S%2FPROS1%2C+CF/pmc12611762-522-33-42
    Average 93 stars, based on 8 article reviews
    recombinant mouse protein s pros1 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Injection:

    Article Title: Inhibition of Mer exacerbates early brain injury by regulating microglia/macrophage phenotype after subarachnoid hemorrhage in mice.
    Article Snippet: rnal of Stroke and Cer Background: Polarization of microglia/macrophages toward the pro-inflammatory phenotype is a crucial contributor to neuroinflammation after subarachnoid hemorrhage (SAH).. Mer belongs to the TAM receptor tyrosine kinases family, which is known to play a significant role in the resolution of inflammation.. However, the effect and mechanism of Mer after SAH remain unclear.

    Recombinant:

    Article Title: Inhibition of Mer exacerbates early brain injury by regulating microglia/macrophage phenotype after subarachnoid hemorrhage in mice.
    Article Snippet: rnal of Stroke and Cer Background: Polarization of microglia/macrophages toward the pro-inflammatory phenotype is a crucial contributor to neuroinflammation after subarachnoid hemorrhage (SAH).. Mer belongs to the TAM receptor tyrosine kinases family, which is known to play a significant role in the resolution of inflammation.. However, the effect and mechanism of Mer after SAH remain unclear.

    Article Title: Mer regulates microglial M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury
    Article Snippet: .. Recombinant protein S (PS) (0.2 mg/kg) (9489-PS, R&D Systems) was administered via the tail vein at 1 h, 1 d, and 2 d after the CCI [25,26]. ..



    Similar Products

    93
    R&D Systems recombinant mouse protein s pros1
    Recombinant Mouse Protein S Pros1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+s+ps/Recombinant+Mouse+Protein+S%2FPROS1%2C+CF/pmc12611762-522-33-42
    Average 93 stars, based on 1 article reviews
    recombinant mouse protein s pros1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems human psa
    Human Psa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+s+ps/Recombinant+Human+Protein+S%2FPROS1%2C+CF/us12434236-526-5-7
    Average 93 stars, based on 1 article reviews
    human psa - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human protein standards
    IGFBP levels in fetal serum. (A) Example Western Ligand Blot showing human <t>recombinant</t> protein standards in the left lane, with the right lane showing the six bands detected in fetal porcine serum. Relative density of (B) a 26 kDa IGFBP, (C) a 28 kDa IGFBP, (D) IGFBP2, (E) the 40 kDa IGFBP3, and (F) IGFBP4 in fetal porcine serum derived from fetuses ( n = 11–12/group) at various gestational timepoints following 21 days of maternal CON or MMI treatment. Relative density was calculated relative to a consistent reference sample run on each gel, with unique letter superscripts denoting statistically significant ( p < 0.05) changes in density in the CON group over time, and statistical differences between the CON and MMI group within each timepoint denoted as * p < 0.05, ** p < 0.01, and *** p < 0.001. Data are presented as the estimated marginal means with 95% confidence intervals, as extracted from a linear model including gestational day, treatment group, and the interaction.
    Recombinant Human Protein Standards, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+s+ps/Recombinant+Human+Protein+S%2FPROS1%2C+CF/pmc12281263-118-13-24
    Average 93 stars, based on 1 article reviews
    recombinant human protein standards - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human protein treatment
    IGFBP levels in fetal serum. (A) Example Western Ligand Blot showing human <t>recombinant</t> protein standards in the left lane, with the right lane showing the six bands detected in fetal porcine serum. Relative density of (B) a 26 kDa IGFBP, (C) a 28 kDa IGFBP, (D) IGFBP2, (E) the 40 kDa IGFBP3, and (F) IGFBP4 in fetal porcine serum derived from fetuses ( n = 11–12/group) at various gestational timepoints following 21 days of maternal CON or MMI treatment. Relative density was calculated relative to a consistent reference sample run on each gel, with unique letter superscripts denoting statistically significant ( p < 0.05) changes in density in the CON group over time, and statistical differences between the CON and MMI group within each timepoint denoted as * p < 0.05, ** p < 0.01, and *** p < 0.001. Data are presented as the estimated marginal means with 95% confidence intervals, as extracted from a linear model including gestational day, treatment group, and the interaction.
    Recombinant Human Protein Treatment, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+s+ps/Recombinant+Human+Protein+S%2FPROS1%2C+CF/pm40319033-390-0-11
    Average 93 stars, based on 1 article reviews
    recombinant human protein treatment - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant pros1
    IGFBP levels in fetal serum. (A) Example Western Ligand Blot showing human <t>recombinant</t> protein standards in the left lane, with the right lane showing the six bands detected in fetal porcine serum. Relative density of (B) a 26 kDa IGFBP, (C) a 28 kDa IGFBP, (D) IGFBP2, (E) the 40 kDa IGFBP3, and (F) IGFBP4 in fetal porcine serum derived from fetuses ( n = 11–12/group) at various gestational timepoints following 21 days of maternal CON or MMI treatment. Relative density was calculated relative to a consistent reference sample run on each gel, with unique letter superscripts denoting statistically significant ( p < 0.05) changes in density in the CON group over time, and statistical differences between the CON and MMI group within each timepoint denoted as * p < 0.05, ** p < 0.01, and *** p < 0.001. Data are presented as the estimated marginal means with 95% confidence intervals, as extracted from a linear model including gestational day, treatment group, and the interaction.
    Recombinant Pros1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+s+ps/Recombinant+Mouse+Protein+S%2FPROS1%2C+CF/10__1158_slash_2326___6066__cir___24___0335-56-111-115
    Average 93 stars, based on 1 article reviews
    recombinant pros1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    R&D Systems sirna transfection recombinant ps
    IGFBP levels in fetal serum. (A) Example Western Ligand Blot showing human <t>recombinant</t> protein standards in the left lane, with the right lane showing the six bands detected in fetal porcine serum. Relative density of (B) a 26 kDa IGFBP, (C) a 28 kDa IGFBP, (D) IGFBP2, (E) the 40 kDa IGFBP3, and (F) IGFBP4 in fetal porcine serum derived from fetuses ( n = 11–12/group) at various gestational timepoints following 21 days of maternal CON or MMI treatment. Relative density was calculated relative to a consistent reference sample run on each gel, with unique letter superscripts denoting statistically significant ( p < 0.05) changes in density in the CON group over time, and statistical differences between the CON and MMI group within each timepoint denoted as * p < 0.05, ** p < 0.01, and *** p < 0.001. Data are presented as the estimated marginal means with 95% confidence intervals, as extracted from a linear model including gestational day, treatment group, and the interaction.
    Sirna Transfection Recombinant Ps, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+s+ps/Recombinant+Human+Protein+S%2FPROS1%2C+CF/pm38639897-42-3-15
    Average 94 stars, based on 1 article reviews
    sirna transfection recombinant ps - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    R&D Systems human recombinant pros1 protein
    Figure 4. MICA+ tumor cells communicated with MMP9+ macrophages via the <t>PROS1-AXL</t> and CCL15-CCR1 pathways. (a,b) The interaction net count and interaction weight plot of HCC cells. The thicker line indicates the higher number of interactions and the stronger weights/strength of interactions between the two cell types. (c) Chord diagram showing all the significant interactions (ligand-receptor pairs) between MICA+/MICA−tumor cells and MMP9+/MMP9−macrophage. (d) The violin plot showing PROS1-AXL/CCL15-CCR1 (ligand-receptor pairs) and some macrophage marker genes expression in different cell clusters. (e) PROS1-AXL/CCL15-CCR1 ligand-receptor pairs and some major IFN-γ signaling pathway genes inside tumor cells and macrophage. Diamonds represent genes that are upregulated in macrophages. Octagons represent genes that are upregulated in tumor cells. The triangles represent transcription factors.
    Human Recombinant Pros1 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+s+ps/Recombinant+Human+Protein+S%2FPROS1%2C+CF/pm38254761-89-18-22
    Average 94 stars, based on 1 article reviews
    human recombinant pros1 protein - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    IGFBP levels in fetal serum. (A) Example Western Ligand Blot showing human recombinant protein standards in the left lane, with the right lane showing the six bands detected in fetal porcine serum. Relative density of (B) a 26 kDa IGFBP, (C) a 28 kDa IGFBP, (D) IGFBP2, (E) the 40 kDa IGFBP3, and (F) IGFBP4 in fetal porcine serum derived from fetuses ( n = 11–12/group) at various gestational timepoints following 21 days of maternal CON or MMI treatment. Relative density was calculated relative to a consistent reference sample run on each gel, with unique letter superscripts denoting statistically significant ( p < 0.05) changes in density in the CON group over time, and statistical differences between the CON and MMI group within each timepoint denoted as * p < 0.05, ** p < 0.01, and *** p < 0.001. Data are presented as the estimated marginal means with 95% confidence intervals, as extracted from a linear model including gestational day, treatment group, and the interaction.

    Journal: Comprehensive Physiology

    Article Title: Porcine Fetal Hypothyroidism Induces Temporal and Tissue‐Specific Alterations in the Insulin‐Like Growth Factor System

    doi: 10.1002/cph4.70028

    Figure Lengend Snippet: IGFBP levels in fetal serum. (A) Example Western Ligand Blot showing human recombinant protein standards in the left lane, with the right lane showing the six bands detected in fetal porcine serum. Relative density of (B) a 26 kDa IGFBP, (C) a 28 kDa IGFBP, (D) IGFBP2, (E) the 40 kDa IGFBP3, and (F) IGFBP4 in fetal porcine serum derived from fetuses ( n = 11–12/group) at various gestational timepoints following 21 days of maternal CON or MMI treatment. Relative density was calculated relative to a consistent reference sample run on each gel, with unique letter superscripts denoting statistically significant ( p < 0.05) changes in density in the CON group over time, and statistical differences between the CON and MMI group within each timepoint denoted as * p < 0.05, ** p < 0.01, and *** p < 0.001. Data are presented as the estimated marginal means with 95% confidence intervals, as extracted from a linear model including gestational day, treatment group, and the interaction.

    Article Snippet: In addition to samples of interest, each blot contained a lane of pooled recombinant human protein standards representing IGFBPs ‐1, ‐2, ‐3, and ‐4 (R&D Systems), which were used as reference points for identification of bands of interest, as well as a lane of pooled fetal serum which was used to calculate the relative density of each band of interest for analysis.

    Techniques: Western Blot, Recombinant, Derivative Assay

    Figure 4. MICA+ tumor cells communicated with MMP9+ macrophages via the PROS1-AXL and CCL15-CCR1 pathways. (a,b) The interaction net count and interaction weight plot of HCC cells. The thicker line indicates the higher number of interactions and the stronger weights/strength of interactions between the two cell types. (c) Chord diagram showing all the significant interactions (ligand-receptor pairs) between MICA+/MICA−tumor cells and MMP9+/MMP9−macrophage. (d) The violin plot showing PROS1-AXL/CCL15-CCR1 (ligand-receptor pairs) and some macrophage marker genes expression in different cell clusters. (e) PROS1-AXL/CCL15-CCR1 ligand-receptor pairs and some major IFN-γ signaling pathway genes inside tumor cells and macrophage. Diamonds represent genes that are upregulated in macrophages. Octagons represent genes that are upregulated in tumor cells. The triangles represent transcription factors.

    Journal: Cancers

    Article Title: MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC).

    doi: 10.3390/cancers16020269

    Figure Lengend Snippet: Figure 4. MICA+ tumor cells communicated with MMP9+ macrophages via the PROS1-AXL and CCL15-CCR1 pathways. (a,b) The interaction net count and interaction weight plot of HCC cells. The thicker line indicates the higher number of interactions and the stronger weights/strength of interactions between the two cell types. (c) Chord diagram showing all the significant interactions (ligand-receptor pairs) between MICA+/MICA−tumor cells and MMP9+/MMP9−macrophage. (d) The violin plot showing PROS1-AXL/CCL15-CCR1 (ligand-receptor pairs) and some macrophage marker genes expression in different cell clusters. (e) PROS1-AXL/CCL15-CCR1 ligand-receptor pairs and some major IFN-γ signaling pathway genes inside tumor cells and macrophage. Diamonds represent genes that are upregulated in macrophages. Octagons represent genes that are upregulated in tumor cells. The triangles represent transcription factors.

    Article Snippet: In certain experiments, the cells were treated with phorbol-12-myristate-13-acetate (PMA) (MedChemExpress, Monmouth Junction, NJ, USA, catalog no. HY-18739/CS-6053), human recombinant Pros1 protein (R&D Systems, Minneapolis, MN, USA, catalog no. 9489-PS) or cabozantinib (MedChemExpress, Monmouth Junction, NJ, USA, catalog no. HY-13016).

    Techniques: Marker, Expressing

    Figure 6. IRF1 upregulated PROS1 in HCC cells and also enhanced PROS1 expression in MICA+ HCC cells. (a) The typical IHC images of MICA, MMP9, PROS1, and AXL in non-tumor and tumor live (×400 magnification). Scale bars are 200 µm. (b,c) PROS1 expression levels of IRF1 and MICA positive tumor cells in scRNA-seq data. (d) PROS1 mRNA expression levels of Huh-7 cells infected by lentivirus IRF1 cDNA or empty vector (NC) (50 MOI) for 48 h. (e) PROS1 protein level of Huh-7 cells infected by lentivirus IRF1 cDNA or empty vector (NC) (50 MOI) for 48 h. The quantitative analyses are shown on the right. (f) PROS1 mRNA expression level of Huh-7 cells infected by lentivirus MICA cDNA or empty vector (NC) (50 MOI) for 48 h. (g) PROS1 protein level of Huh-7 cells infected by lentivirus MICA cDNA or empty vector (NC) (50 MOI) for 48 h. The quantitative analyses are shown on the right. (h,i) The typical IF images show PROS1 protein level (red staining) in Huh-7 cells which were respectively transfected with lentiviral IRF1 and MICA (×200 magnification). Scale bars are 150 µm. Quantification of PROS1 via relative fluorescent intensity is shown. ** p < 0.01, *** p < 0.001, via two-tailed unpaired t-test. The original uncropped western blot images are shown in Supplementary Figure S5.

    Journal: Cancers

    Article Title: MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC).

    doi: 10.3390/cancers16020269

    Figure Lengend Snippet: Figure 6. IRF1 upregulated PROS1 in HCC cells and also enhanced PROS1 expression in MICA+ HCC cells. (a) The typical IHC images of MICA, MMP9, PROS1, and AXL in non-tumor and tumor live (×400 magnification). Scale bars are 200 µm. (b,c) PROS1 expression levels of IRF1 and MICA positive tumor cells in scRNA-seq data. (d) PROS1 mRNA expression levels of Huh-7 cells infected by lentivirus IRF1 cDNA or empty vector (NC) (50 MOI) for 48 h. (e) PROS1 protein level of Huh-7 cells infected by lentivirus IRF1 cDNA or empty vector (NC) (50 MOI) for 48 h. The quantitative analyses are shown on the right. (f) PROS1 mRNA expression level of Huh-7 cells infected by lentivirus MICA cDNA or empty vector (NC) (50 MOI) for 48 h. (g) PROS1 protein level of Huh-7 cells infected by lentivirus MICA cDNA or empty vector (NC) (50 MOI) for 48 h. The quantitative analyses are shown on the right. (h,i) The typical IF images show PROS1 protein level (red staining) in Huh-7 cells which were respectively transfected with lentiviral IRF1 and MICA (×200 magnification). Scale bars are 150 µm. Quantification of PROS1 via relative fluorescent intensity is shown. ** p < 0.01, *** p < 0.001, via two-tailed unpaired t-test. The original uncropped western blot images are shown in Supplementary Figure S5.

    Article Snippet: In certain experiments, the cells were treated with phorbol-12-myristate-13-acetate (PMA) (MedChemExpress, Monmouth Junction, NJ, USA, catalog no. HY-18739/CS-6053), human recombinant Pros1 protein (R&D Systems, Minneapolis, MN, USA, catalog no. 9489-PS) or cabozantinib (MedChemExpress, Monmouth Junction, NJ, USA, catalog no. HY-13016).

    Techniques: Expressing, Infection, Plasmid Preparation, Staining, Transfection, Two Tailed Test, Western Blot

    Figure 7. MICA+ HCC cell stimulated MMP9 secretion via PROS1-AXL axis and promoted proteolytic shedding of MICA into soluble MICA (sMICA). (a) MMP9, AXL, CD163 and CD206 mRNA expression was detected via qPCR in Huh-7 cells stimulated by recombinant human PROS1 protein 2 µg/mL for 72 h. (b) The whole lysate for PROS1 and AXL protein determined via western blot is shown in macrophage stimulated by recombinant human PROS1 protein for 72 h. The quantitative analyses are shown on the right. (c,d) The level of MMP9 and soluble MICA in the conditioned medium was determined via an ELISA procedure. (e) MMP9 mRNA expression was detected via qPCR in macrophage co-cultured with MICA+ and NC Huh7 cells. The whole lysate for MMP9 protein determined via western blot is shown in macrophage cultured with MICA+ and NC Huh7 cells. The quantitative analyses are shown on the right. (f) MMP9 mRNA expression was detected via qPCR in macrophage co-cultured with IRF1+ and NC Huh7 cells. The whole lysate for MMP9 protein determined via western blot is shown in macrophage cultured by IRF1+ and NC Huh7 cells. The quantitative analyses are shown on the right. (g) MMP9 protein expression was measured via western blot in macrophage stimulated by preconditioned cabozantinib (5 µM) and recombinant human PROS1 protein for 72 h. The quantitative analyses are shown on the right. (h) MMP9 protein expression was measured via western blot in macrophage co-cultured with IRF1+ and NC Huh7 cells treated by cabozantinib (5 µM). The quantitative analyses are shown on the right. * p < 0.05, ** p < 0.01, *** p < 0.001, via two-tailed unpaired t-test. The original western blots are shown in Supplementary Figure S5.

    Journal: Cancers

    Article Title: MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC).

    doi: 10.3390/cancers16020269

    Figure Lengend Snippet: Figure 7. MICA+ HCC cell stimulated MMP9 secretion via PROS1-AXL axis and promoted proteolytic shedding of MICA into soluble MICA (sMICA). (a) MMP9, AXL, CD163 and CD206 mRNA expression was detected via qPCR in Huh-7 cells stimulated by recombinant human PROS1 protein 2 µg/mL for 72 h. (b) The whole lysate for PROS1 and AXL protein determined via western blot is shown in macrophage stimulated by recombinant human PROS1 protein for 72 h. The quantitative analyses are shown on the right. (c,d) The level of MMP9 and soluble MICA in the conditioned medium was determined via an ELISA procedure. (e) MMP9 mRNA expression was detected via qPCR in macrophage co-cultured with MICA+ and NC Huh7 cells. The whole lysate for MMP9 protein determined via western blot is shown in macrophage cultured with MICA+ and NC Huh7 cells. The quantitative analyses are shown on the right. (f) MMP9 mRNA expression was detected via qPCR in macrophage co-cultured with IRF1+ and NC Huh7 cells. The whole lysate for MMP9 protein determined via western blot is shown in macrophage cultured by IRF1+ and NC Huh7 cells. The quantitative analyses are shown on the right. (g) MMP9 protein expression was measured via western blot in macrophage stimulated by preconditioned cabozantinib (5 µM) and recombinant human PROS1 protein for 72 h. The quantitative analyses are shown on the right. (h) MMP9 protein expression was measured via western blot in macrophage co-cultured with IRF1+ and NC Huh7 cells treated by cabozantinib (5 µM). The quantitative analyses are shown on the right. * p < 0.05, ** p < 0.01, *** p < 0.001, via two-tailed unpaired t-test. The original western blots are shown in Supplementary Figure S5.

    Article Snippet: In certain experiments, the cells were treated with phorbol-12-myristate-13-acetate (PMA) (MedChemExpress, Monmouth Junction, NJ, USA, catalog no. HY-18739/CS-6053), human recombinant Pros1 protein (R&D Systems, Minneapolis, MN, USA, catalog no. 9489-PS) or cabozantinib (MedChemExpress, Monmouth Junction, NJ, USA, catalog no. HY-13016).

    Techniques: Expressing, Recombinant, Western Blot, Enzyme-linked Immunosorbent Assay, Cell Culture, Two Tailed Test

    Figure 8. System illustration of MICA+ tumor cell upregulated macrophage-secreted MMP9 via PROS1-AXL axis to induce tumor immune escape in advanced HCC. (a) IRF1 transcriptionally upregulated MICA expression to activate NKG2D-mediated anti-tumor immune responses by CD8+ T cells. (b) DNA damage induced MICA and PROS1 expression via IRF1. PROS1 activated MMP9 secreted from macrophages via AXL receptor to hydrolyze MICA. The release of soluble MICA (sMICA) promoted immune evasion by the tumor.

    Journal: Cancers

    Article Title: MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC).

    doi: 10.3390/cancers16020269

    Figure Lengend Snippet: Figure 8. System illustration of MICA+ tumor cell upregulated macrophage-secreted MMP9 via PROS1-AXL axis to induce tumor immune escape in advanced HCC. (a) IRF1 transcriptionally upregulated MICA expression to activate NKG2D-mediated anti-tumor immune responses by CD8+ T cells. (b) DNA damage induced MICA and PROS1 expression via IRF1. PROS1 activated MMP9 secreted from macrophages via AXL receptor to hydrolyze MICA. The release of soluble MICA (sMICA) promoted immune evasion by the tumor.

    Article Snippet: In certain experiments, the cells were treated with phorbol-12-myristate-13-acetate (PMA) (MedChemExpress, Monmouth Junction, NJ, USA, catalog no. HY-18739/CS-6053), human recombinant Pros1 protein (R&D Systems, Minneapolis, MN, USA, catalog no. 9489-PS) or cabozantinib (MedChemExpress, Monmouth Junction, NJ, USA, catalog no. HY-13016).

    Techniques: Expressing